2022-01-04-光大新鸿基-每日投资摘要_15页_1mb

Market Overview (January 4, 2022): Hong Kong markets experienced volatility, with the Hang Seng Index (HSI) ending at 23,275 points, down 0.53% for the day and 0.5% year-to-date, while the China Enterprises Guild Index (CEG) fell 0.58%. US markets saw gains, with the S&P 500 up 0.6%, Nasdaq up 1.2%, and Dow Jones up 0.7%. Factors included global economic uncertainty, US building expenditure data, and COVID impacts.

Key Market Events:

• Corporate News: CRESCENT SERVICE terminated an acquisition deal due to funding issues; BaseStone Pharmaceutical received clinical trial approval for a lung cancer drug.
• Global Impact: US economic data showed mixed results, with oil and gold prices fluctuating due to market conditions and supply chain concerns.

Sector Performance:

• Energy and pharma sectors led gains, with power stocks (e.g., China Resources Power, China Shenhua) rising due to policy support on clean energy. Pharma stocks surged as China included traditional medicine in healthcare coverage.
• Hong Kong's stock exchange and airline sector saw modest moves, offset by broader market weakness. Top performers included healthcare firms like China Drugs and Xinjiang Chemical.

Focus Shares:

• NIO (US-listed EV maker) trailed other "new energy vehicle" stocks due to slower rebound, with analysts suggesting a 12-month target of 35.00 HKD, stop-loss at 28.00 HKD.

IPO Highlights: Limited data; recent IPOs showed mixed performance, with some stocks underperforming due to sector risks.

Macro Data: US interest rates, currency exchange rates, and commodity prices (e.g., oil up 0.87%, gold down 28.5%) influenced global markets. Hong Kong's SHIBOR edged down.

A/H Stock Differences: Significant discounts in H shares (e.g., up to 200% for some companies) reflected regulatory and market sentiment disparities.